Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs

被引:2
|
作者
Tong, Huichun [1 ]
Yang, Tianqi [1 ]
Liu, Li [1 ]
Li, Caijuan [1 ]
Sun, Yize [1 ]
Jia, Qingqing [1 ]
Qin, Yiyang [1 ]
Chen, Laiqiang [1 ]
Zhao, Xianxian [1 ]
Zhou, Gongke [1 ]
Yan, Sen [1 ]
Li, Xiao-Jiang [1 ]
Li, Shihua [1 ]
机构
[1] Jinan Univ, Guangdong Hongkong Macau Inst CNS Regenerat, Guangdong Key Lab Nonhuman Primate Res, Guangzhou 510632, Peoples R China
基金
美国国家科学基金会;
关键词
Aberrant splicing; Htt exon1 fragments; Htt N -terminal fragments; PROTEIN; EXPRESSION; GENE;
D O I
10.1016/j.nbd.2023.106291
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is an autosomal-dominant inherited neurodegenerative disease caused by a CAG repeat expansion in exon1 of the huntingtin gene (HTT). This expansion leads to the production of N-terminal mutant huntingtin protein (mHtt) that contains an expanded polyglutamine tract, which is toxic to neurons and causes neurodegeneration. While the production of N-terminal mHtt can be mediated by proteolytic cleavage of full-length mHtt, abnormal splicing of exon1-intron1 of mHtt has also been identified in the brains of HD mice and patients. However, the proportion of aberrantly spliced exon1 mHTT in relation to normal mHTT exon remains to be defined. In this study, HTT exon1 production was examined in the HD knock-in (KI) pig model, which more closely recapitulates neuropathology seen in HD patient brains than HD mouse models. The study revealed that aberrant spliced HTT exon1 is also present in the brains of HD pigs, but it is expressed at a much lower level than the normally spliced HTT exon products. These findings suggest that careful consideration is needed when assessing the contribution of aberrantly spliced mHTT exon1 to HD pathogenesis, and further rigorous investigation is required.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene
    Franich, Nicholas R.
    Hickey, Miriam A.
    Zhu, Chunni
    Osborne, Georgina F.
    Ali, Nadira
    Chu, Tiffany
    Bove, Nicholas H.
    Lemesre, Vincent
    Lerner, Renata P.
    Zeitlin, Scott O.
    Howland, David
    Neueder, Andreas
    Landles, Christian
    Bates, Gillian P.
    Chesselet, Marie-Francoise
    JOURNAL OF NEUROSCIENCE RESEARCH, 2019, 97 (12) : 1590 - 1605
  • [3] Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells
    Ribeiro, Marcio
    Rosenstock, Tatiana R.
    Cunha-Oliveira, Teresa
    Ferreira, Ildete L.
    Oliveira, Catarina R.
    Cristina Rego, A.
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (10) : 1857 - 1867
  • [4] Analysis of mutant and total huntingtin expression in Huntington's disease murine models
    Fodale, Valentina
    Pintauro, Roberta
    Daldin, Manuel
    Altobelli, Roberta
    Spiezia, Maria Carolina
    Bisbocci, Monica
    Macdonald, Douglas
    Bresciani, Alberto
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [5] Decreased BDNF Release in Cortical Neurons of a Knock-in Mouse Model of Huntington's Disease
    Yu, Chenglong
    Li, Chun Hei
    Chen, Sidong
    Yoo, Hanna
    Qin, Xianan
    Park, Hyokeun
    SCIENTIFIC REPORTS, 2018, 8
  • [6] Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form
    Yang, Huiming
    Yang, Su
    Jing, Liang
    Huang, Luoxiu
    Chen, Luxiao
    Zhao, Xianxian
    Yang, Weili
    Pan, Yongcheng
    Yin, Peng
    Qin, Zhaohui S.
    Li, Shihua
    Li, Xiao-Jiang
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [7] Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin
    Tan, Z.
    Dai, W.
    van Erp, T. G. M.
    Overman, J.
    Demuro, A.
    Digman, M. A.
    Hatami, A.
    Albay, R.
    Sontag, E. M.
    Potkin, K. T.
    Ling, S.
    Macciardi, F.
    Bunney, W. E.
    Long, J. D.
    Paulsen, J. S.
    Ringman, J. M.
    Parker, I.
    Glabe, C.
    Thompson, L. M.
    Chiu, W.
    Potkin, S. G.
    MOLECULAR PSYCHIATRY, 2015, 20 (11) : 1286 - 1293
  • [8] Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease
    Bertoglio, Daniele
    Bard, Jonathan
    Hessmann, Manuela
    Liu, Longbin
    Gaertner, Annette
    De Lombaerde, Stef
    Huscher, Britta
    Zajicek, Franziska
    Miranda, Alan
    Peters, Finn
    Herrmann, Frank
    Schaertl, Sabine
    Vasilkovska, Tamara
    Brown, Christopher J.
    Johnson, Peter D.
    Prime, Michael E.
    Mills, Matthew R.
    Van der Linden, Annemie
    Mrzljak, Ladislav
    Khetarpal, Vinod
    Wang, Yuchuan
    Marchionini, Deanna M.
    Skinbjerg, Mette
    Verhaeghe, Jeroen
    Dominguez, Celia
    Staelens, Steven
    Munoz-Sanjuan, Ignacio
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (630)
  • [9] Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice
    Caron, Nicholas S.
    Banos, Raul
    Aly, Amirah E.
    Xie, Yuanyun
    Ko, Seunghyun
    Potluri, Nalini
    Anderson, Christine
    Black, Hailey Findlay
    Anderson, Lisa M.
    Gordon, Benjamin
    Southwell, Amber L.
    Hayden, Michael R.
    NEUROBIOLOGY OF DISEASE, 2022, 166
  • [10] Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington's disease patients
    Pierzynowska, Karolina
    Gaffke, Lidia
    Cyske, Zuzanna
    Wegrzyn, Grzegorz
    METABOLIC BRAIN DISEASE, 2019, 34 (03) : 715 - 720